Nelarabine

In the US, Nelarabine (nelarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia and Lymphoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BB07

CAS registry number (Chemical Abstracts Service)

0121032-29-9

Chemical Formula

C11-H15-N5-O5

Molecular Weight

297

Therapeutic Categories

Cytostatic agent

Antimetabolite

Chemical Names

2-Amino-β-D-arabinofuranosyl-6-methoxy-9H-purine (WHO)

9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine (USAN)

9-(β-D-Arabinofuranosyl)-6-methoxypurin-2-amin (IUPAC)

Foreign Names

  • Nelarabinum (Latin)
  • Nelarabin (German)
  • Nelarabine (French)
  • Nelarabina (Spanish)

Generic Names

  • Nelarabine (OS: BAN, USAN)
  • 506U (IS)
  • 506U78 (IS)
  • GW 506U78 (IS)
  • MAY (IS: GlaxoWellcome)
  • Nelzarabine (IS)
  • NSC-686673 (IS)
  • U78 (IS)

Brand Names

  • Arranon
    GlaxoSmithKline, United States
  • ArranonG
    GlaxoSmithKline, Japan
  • Atriance
    Glaxo, Latvia; Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Group, Slovenia; GlaxoGroup, Netherlands; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Norway; GlaxoSmithKline, Portugal; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Greece

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)